Enterprise Pharmacy: An ecosystem of connected care
Geisinger Enterprise Pharmacy functions as an interconnected ecosystem, with more than 1,200 professionals coordinating care, access, operations and resources across the patient journey.
Latest
Rounding the Right Way: Creating a Consistent Foundation for Acute Care Pharmacy Practice
Clinical pharmacists bring deep medication expertise to every patient encounter, but inconsistent workflows can limit their impact. “Rounding the Right Way” is standardizing pharmacist rounding to improve reliability, efficiency, and high-value patient care.
Getting ahead of hypertension: Pharmacists join care earlier to accelerate blood pressure control
A new hypertension management workflow is bringing Geisinger pharmacists into care earlier, helping primary care teams respond more quickly when blood pressure remains elevated and giving patients a clearer path toward control.
Pharmacy-led naloxone outreach expands access across Geisinger communities
Geisinger pharmacy teams are expanding naloxone access through community-based outreach, education, and public-access boxes, helping families, neighbors, and bystanders be ready to respond when minutes matter.
Why Residency Training Matters to Geisinger Pharmacy
More than 75% of Geisinger’s 2026 pharmacy residency graduates stayed with the organization—as employees or as second-year residents. That number tells a story about training, mentorship, and the kind of professional community residents experience here.
Pharmacist Provider Status Recognized by Medicaid: Building the Framework for Billing
Stacey Grassi, Daniel Longyhore and Leeann Webster
On March 1, 2024, Pennsylvania State Medicaid announced the inclusion of pharmacists as providers, allowing them to bill and be reimbursed for patient visits and other services.
This milestone follows several years of collaboration with the Pennsylvania Department of Human Services, with Geisinger’
Expanding behavioral health pharmacy services through the Geisinger–Acadia Partnership
Brian Simpkins
In 2023, Geisinger and Acadia Healthcare launched a joint venture to expand behavioral health services across the Geisinger service region. The partnership began with the opening of Geisinger Behavioral Health Northeast in Moosic, Pa., followed by the launch of a second facility in Danville in August 2025.
These
Expanding Care Beyond Walls: Launching Geisinger’s Hospital at Home Program
Michelle Budzyn and Kelly Bolesta
Geisinger’s Hospital at Home program is an innovative initiative that offers patients hospital-level care from the comfort of their own homes. The program allows patients to remain close to family, friends and pets; avoid unnecessary exposure to infection; and continue healing in safety
Geisinger Pharmacy value creation in a pluralistic healthcare environment
Jonathan Brady, Allison Cebulko and Seth Gazes
Each year, Enterprise Pharmacy develops a strategic project portfolio aimed at improving organizational financial performance as part of the Geisinger Transformation (GT) program.
The pharmacy team operates under a dual mandate:
1. To mitigate overall drug trend while maintaining the quality of care
Transforming cancer care: Expanding home infusion access for blinatumomab therapy
Benjamin Andrick, Ron Zsido and Nichole Varela-Gonzalez
Over the past year, the health system continued to advance cancer care delivery by expanding access to high-acuity therapies in the home setting. Among the most impactful initiatives was the development and implementation of a coordinated home infusion program for blinatumomab,
Geisinger Cancer Center Dickson City opens, expanding access to advanced oncology care
Justine Zuk and Ralph Ferraro
On June 23, the new Geisinger Cancer Center Dickson City welcomed its first patient, marking a major milestone in the expansion of advanced cancer care across northeastern Pennsylvania. This momentous occasion reflects the culmination of months of tireless dedication and teamwork. Every member of the
From purchase to patient: Geisinger’s AI-powered approach to drug diversion prevention
Barbara Zirnhelt
Drug diversion continues to pose a significant and persistent challenge for healthcare systems across the country. Even with strict adherence to professional standards and regulatory requirements, many organizations still lack a fully integrated, systemwide approach to effectively reduce the risks associated with controlled substances. At Geisinger, we have
Tenecteplase is here: Navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers and pathways
Julian M. Burwell, Jason R. Howay, Lisa Wasko, Samantha Doucoure, Jamie L. Kerestes, Clemens M. Schirmer, David Ermak, Anthony Noto, Philipp Hendrix
Until March 2025, alteplase (TPA) was the sole thrombolytic agent approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute ischemic stroke (AIS)
Pharmacy Stars platform drives systemwide standardization in compounding competencies
Heidi Yanoski and Adam Castro
Over the past year, the transition of Geisinger’s aseptic technique competencies to the Pharmacy Stars® online platform was successfully completed, with the official launch occurring on March 1, 2025. This initiative involved extensive cross-departmental planning and customization to meet systemwide requirements. Instructional resources